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Abstract
Background: Toxoplasma gondii is an obligate intracellular protozoan that infects 20 to 90% of the population. It can cause
both acute and chronic infections, many of which are asymptomatic, and, in immunocompromized hosts, can cause fatal
infection due to reactivation from an asymptomatic chronic infection. An essential step towards understanding molecular
mechanisms controlling transitions between the various life stages and identifying candidate drug targets is to accurately
characterize the T. gondii proteome.
Methodology/Principal Findings: We have explored the proteome of T. gondii tachyzoites with high throughput
proteomics experiments and by comparison to publicly available cDNA sequence data. Mass spectrometry analysis
validated 2,477 gene coding regions with 6,438 possible alternative gene predictions; approximately one third of the T.
gondii proteome. The proteomics survey identified 609 proteins that are unique to Toxoplasma as compared to any known
species including other Apicomplexan. Computational analysis identified 787 cases of possible gene duplication events and
located at least 6,089 gene coding regions. Commonly used gene prediction algorithms produce very disparate sets of
protein sequences, with pairwise overlaps ranging from 1.4% to 12%. Through this experimental and computational
exercise we benchmarked gene prediction methods and observed false negative rates of 31 to 43%.
Conclusions/Significance: This study not only provides the largest proteomics exploration of the T. gondii proteome, but
illustrates how high throughput proteomics experiments can elucidate correct gene structures in genomes.
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Introduction
Toxoplasma gondii is an obligate intracellular protozoan, belong-
ing to the phylum Apicomplexa and is an important pathogen in
both immune competent and immune compromised humans. The
parasite causes chronic infection in adults and is present in an
estimated 22.5% of people older than 12 in the United States [1]
and up to 90% of the population in other regions of the world [2].
Acute infection is typically not symptomatic. Reactivation of latent
infections is seen in immune compromised individuals, where
infection often presents as encephalitis. T. gondii clinical disease is
most typical in immune compromised individuals and is a
common opportunistic pathogen associated with AIDS.
T. gondii has a wide range of hosts including almost all
mammals as well as birds. It exists in three life stages. Oocysts are
produced in the definitive host, the cat, and are environmentally
resistant, surviving for prolonged periods of time in water, thus
causing potential waterborne illness. Bradyzoites, found in the
intermediate hosts, are slow growing parasites contained in
vacuoles, which form tissue cysts and are generally unrecognized
by the host’s immune system. Bradyzoite tissue cysts can be
transmitted via ingestion of undercooked, infected meat products
or contaminated water. Once the parasite is present in the host,
bradyzoites or sporozoites differentiate into the tachyzoite stage,
which is responsible for the dissemination and clinically apparent
infection. Due to waterborne outbreaks associated with ocular
toxoplasmosis [3], T. gondii is classified by the National Institute
of Allergy and Infectious Diseases as a Category B priority
pathogen.
T. gondii is an important model system for the phylum
Apicomplexa [4], which includes, among others, Plasmodium
(malaria) and Cryptosporidium species. Unlike many other Apicom-
plexa, which are experimentally intractable, T. gondii is easily
cultured in vitro, has well established experimental protocols for
genetic manipulation, and has a well characterized mouse model
[5].
PLoS ONE | www.plosone.org 1 December 2008 | Volume 3 | Issue 12 | e3899A whole genome shotgun sequence of T. gondii has been
generated by The Institute for Genomic Research (TIGR; now the
J. Craig Venter Institute) at 126 coverage (available at http://
www.toxodb.org), and additional genome sequence is available
from the Sanger Centre (http://www.sanger.ac.uk/Projects/
Protozoa). Initially, three gene prediction algorithms, TigrScan
[6], TwinScan [7], and GlimmerHMM [6], were employed by
TIGR and ToxoDB.org to identify genes in the ME49 strain of T.
gondii. TigrScan and GlimmerHMM are Generalized Hidden
Markov Model, ab initio gene prediction methods. The two models
differ in their underlying statistical methods; TigrScan employs
weight matrices and Markov chains, while GlimmerHMM
incorporates additional splice site models. TwinScan combines
comparative genomics and the probability model approach by
integrating local genomic alignments from related species and ab
initio methods. TwinScan was run using Eimeria tenella as the
informant sequence. A fourth dataset of ME49-strain gene
predictions was developed by ToxoDB and is currently available
from version release 4.3 [8]. The Release4 predictions were
produced using GLEAN [9], an algorithm that creates consensus
gene predictions by integrating available experimental data such
as expressed sequence tags (ESTs) and proteomics data. The
computational gene prediction methods produce protein sequence
sets that represent the theoretical proteome of Toxoplasma gondii;
however, the datasets of predicted protein sequences are quite
different and are likely to introduce substantial inaccuracy [10–
12]. Without experimental verifications it is not possible to assess
whether any of the datasets offer a comprehensive view of the T.
gondii proteome or which datasets, if any, are more accurate than
the others.
Large scale proteomics approaches have been used to analyze
genomes of various organisms such as S. cerevisiae [13], M. mobile
[14], C. parvum [15], T. gondii [16] and S. luteogriseus [17]. Targeted
studies of T. gondii rhoptry [18], secretory [19], and micronemal
[20] proteins highlight the value of applying proteomics to explore
important subproteomes. Further, proteomics can be used to
elucidate the role of post-translational modifications, such as N-
glycosylation, in the function of important proteins [21].
We hypothesize that a systems-level analysis of the T. gondii
proteome, using an approach that integrates proteomics and
bioinformatics, will identify novel proteins that represent unique
chemotherapeutic targets or have important biological functions
during the obligate intracellular development of the parasite. We
assembled a database comprising all computationally and
experimentally derived sequences in an effort to capture the
complete hypothetical proteome of T. gondii. Functional annota-
tion of the proteome, using motif prediction methods, helped to
gain insight into the biological relevance of the predicted proteins.
Comparative genomics identified those proteins that were unique
to T. gondii. Finally, MS and EST data were mapped to the
experimentally derived and computationally generated proteins to
experimentally validate predicted sequences and to assess the
accuracy of various gene prediction methods.
Results
High throughput proteomics analysis of T. gondii
We explored the T. gondii proteome by performing tandem mass
spectrometry (MS/MS) experiments on T. gondii plasma mem-
brane, cytoskeletal and cytosolic protein preparations. A total of
252 MS/MS experiments provided 7,270 (203,990) unique (and
redundant) proteolytic peptides with an average false discovery
rate of approximately 2% based on peptide detection in a ‘‘decoy’’
database (Table 1). The decoy database was generated by Mascot
(www.matrixscience.com) in the following way: during the search,
every time a protein sequence from the target database is tested, a
random sequence of the same length is automatically generated
and tested. The average amino acid composition of the random
sequences is the same as the average composition of the target
database. Peptides were searched against human and mycoplasma
protein databases to remove potential contaminating peptides.
The MS/MS peptides were searched against the hypothetical T.
gondii proteome, comprised of all computationally predicted and
experimental sequences, to identify experimentally supported
sequences. Expressed sequence tag data was used to provide
further experimental support for some proteins in the T. gondii
proteome. All MS data and analysis is publicly accessible in full
depth at the Web site of the Albert Einstein Biodefense Proteomics
Research Center (http://www.fiserlab.org/biodefense and http://
www.fiserlab.org/epicdb ) and summaries have been deposited to
the NIH maintained Resource Center for Biodefense Proteomics
Research, website http://www.proteomicsresource.org/ and to
ToxoDB (http://www.toxodb.org).
Predicted and experimentally known proteins of T. gondii
The hypothetical proteome, comprised of 30,197 amino acid
sequences, combines predicted proteins from the TigrScan (8,336
sequences), TwinScan (7,588), Glimmer (4,954), and Release4
(7,793) datasets, and the available T. gondii sequences from the
NCBI non-redundant protein database (1,526) (NR).
The majority of the sequences in the combined dataset (94%)
are less than 2,000 residues long though some sequences are as
long as 14,514 residues. The averages, ranges, and distributions of
the sequence lengths already suggest substantial differences among
the protein datasets (Table 2, Fig. 1). Glimmer predicted
sequences (1,077 residues average length) are, on average, much
longer than the TigrScan, TwinScan, Release4, or NR sequences
(681, 614, 719, and 510 residues average length, respectively).
Furthermore, the maximum sequence length for TigrScan (9,696
residues) is substantially shorter than the maximum lengths of the
TwinScan, Glimmer, Release4, or NR sequences (13,936, 14,514,
11,862, and 12,269 residues, respectively). The NR sequences
have the shortest average length (510 residues) and the distribution
shows the highest frequency of sequences of approximately 200–
300 residues. The median lengths for each distribution, compared
among each dataset, mimic the characteristics of the differences in
average lengths. The Glimmer sequences had the highest median
length (695), followed by Release4 (472), TigrScan (457),
TwinScan (395), and the NR sequences (341). The shorter
average and median lengths of the NR sequences is not necessarily
an inherent characteristic of T. gondii proteins but could be an
artifact because the researched proteins are likely not a
Table 1. Number, average length, and average MASCOT
score for all peptides identified by MASCOT when the MS
results were searched against the amino acid sequences in
the combined dataset.
Number of MS/MS experiments 252
Number of identified MS/MS peptides
redundant peptides 203,990
unique peptides 7,270
Average peptide length (residues) 15.3
Average MASCOT ion score 63.14
doi:10.1371/journal.pone.0003899.t001
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predominance of shorter sequences could be a consequence of the
greater ease of studying these proteins experimentally, especially in
the past.
The substantial differences in the length characteristics of the
predicted proteins suggest that the algorithms either predict
sequences from vastly different genes and coding regions or that
there are significant disparities in the prediction of the structure
and splicing of the exons and introns within similar gene coding
regions.
Comparing protein sequences obtained from different
prediction methods
Identical or nearly identical proteins in the hypothetical
proteome were grouped in order to explore the overlap and
differences among the computational gene prediction methods.
Each gene finder was employed on the same genome and,
consequently, the four methods ideally should have predicted
identical genes. Of course, conversely, the algorithms may have
also predicted different splicing among predicted exons of the
same open reading frame, predicted different open reading frame
initiation or termination points, or added and/or missed entire
open reading frames, thus generating some vastly different
proteins. If each gene prediction method (TigrScan, TwinScan,
Glimmer, and Release4) produced the same predicted sequence,
those sequences would be clustered together. Grouping identical
proteins in the combined dataset results in 25,908 clusters (86% of
the original set), of which, only 101 contain predicted sequences
from all four methods (Table 3). The numbers of identical
sequence groups with a sequence from one (22,556 groups), two
(2,058), three (521), or all four (101) prediction methods confirms
the observation that the gene prediction methods produce very
different results, with many unique sequences for each prediction
method. The percentage of unique sequences that is produced by
each prediction method is roughly similar for the TigrScan,
TwinScan, and Glimmer methods (76–87% of all predictions),
with Release4 having a slightly smaller percentage of unique
sequences (68%) (Table 3). In general, any two prediction methods
share less than 12% (and as low as 1.4%) identical predicted genes
in a head-to-head comparison. The above analysis does not
insinuate that any one gene finder algorithm is superior to the
others. However, the results provide an initial basis for the effort of
examining all available sequences from each computational
annotation of the genome when examining the proteome.
Clustering predicted proteins by sequence similarity
Discrepancies in protein sequences that are transcribed from
similar genomic locations, whether the result of prediction
differences or splicing variability, likely account for most of the
disparities among the protein datasets. Therefore, in order to
assess the fraction of sequences that are not identical yet share a
common part and, thus, may have been derived from the same
genomic location, the hypothetical proteome of 30,197 sequences
was clustered with a 90% sequence identity threshold requirement.
The clusters were constructed by aligning each sequence with the
longest sequence in a cluster, which is called the ‘‘representative
sequence’’ (see Methods), while allowing large gaps in the
alignment. The number of identical amino acid residues within
regions of sequence overlap was normalized over the length of the
shorter sequence to determine the sequence identity between the
Figure 1. Frequency distribution of sequence lengths (amino acid residues per sequence) for TigrScan (dark blue), TwinScan
(green), Glimmer (red), Release4 (light blue), and NR (grey) sequences. The frequencies are normalized to the total number of sequences in
each dataset. The large graph shows the distributions for sequence lengths of 0–3,000 amino acids. The inset shows the same distributions but for
sequence lengths of 0–500 amino acids.
doi:10.1371/journal.pone.0003899.g001
Validation of Gene Predictions
PLoS ONE | www.plosone.org 3 December 2008 | Volume 3 | Issue 12 | e3899aligned sequences. This approach can group together sequences
with very different lengths if the overlapping parts share more than
90% sequence identity. This clustering strategy is an obvious way
to assess redundancy among the datasets, but it is also a way to
examine potential splicing variability within the genome. Alterna-
tive splicing events such as alternative 59 or 39 exon splice sites,
skipped exons, or retained introns result in sequences that are
splice variants of the same gene. Although the sequences are
different, the local similarities allow them to be clustered together
(Fig. 2a–c).
Clustering by sequence similarity allows for an interpretation of
a comprehensive set of genes and open reading frames that are
predicted by various gene finder algorithms. A cluster of similar
sequences (or a single sequence) is representative of a predicted
gene at the genomic locus despite the fact that there may be some
discrepancy in the exact structure of the gene in question due to
differences in the predicted sequences. This method of clustering
by local sequence similarity is a distinct analysis compared to the
evaluation of identical sequence overlap produced by the gene
finder algorithms. Additionally, the local sequence-similarity
clustering, which encompasses all subsequent clustering analysis,
was performed on the redundant set of 30,197 protein sequences
because the ensuing statistics regarding the differences among the
prediction methods would be artificially affected if some sequences
were removed from the dataset in cases in which two or more
prediction algorithms produced identical sequences.
The hypothetical proteome of 30,197 sequences collapses to
14,983 non-redundant clusters with an average size of 2.02
sequences. The majority of the clusters (55%) are individual
sequences (Table 4), strengthening the observation that there are
many unique sequences that do not share even a common sub-
sequence with other proteins and that the predicted protein
datasets provide remarkably different alternatives. If the 8,281
unique sequences (singleton clusters) are removed from the
original combined dataset, there are 21,916 remaining sequences
that are clustered with at least one other sequence i.e., about 73%
of the combined dataset is redundant, based on sequence
similarity. The elimination of the singleton clusters was performed
only for the aforementioned evaluation of the degree of
redundancy in the dataset. The singleton clusters were included
in all other analyses.
The percentages of the clusters that contain a TigrScan,
TwinScan or Release4 sequence are similar (53%, 47%, and 49%,
respectively), while the percentages that contain a Glimmer or NR
sequence are much lower (33% and 6% respectively) (Table 5).
The differences for the Glimmer predictions and the NR
sequences could be explained by the fact that these datasets,
especially the NR, are significantly smaller then the datasets for the
other three prediction methods. The small fractions of common
protein predictions suggest that any single prediction dataset either
covers a small portion of the theoretical T. gondii genome (,50%
or less) and/or produces a very large percentage of false positives.
Table 3. Number of identical sequence groups containing one, two, three, or all four types (TigrScan, TwinScan, Glimmer,
Release4) of protein prediction methods.
Overlap Among Prediction Methods Number Of Identical Sequence Groups
All (4) Prediction Methods Agree (Tigr,Twin,Glimmer,Release4) 101
Three Prediction Methods Agree 521
Two Prediction Methods Agree 2,058
Single Prediction Method 22,556
unique Tigr=7,245
unique Twin=5,778
unique Glimmer=4,252
unique Release4=5,281
doi:10.1371/journal.pone.0003899.t003
Table 2. Length characteristics (average, standard deviation, and range) and experimental data (MS peptides, MS coverage, EST
alignments, MS AND EST data), for sequence of each prediction type.
Predicted Protein Types
TigrScan TwinScan Glimmer Release4 NR
Total Number of Sequences 8,336 7,588 4,954 7,793 1,526
Length Characteristics
Sequence Length, average6stdev 6816733 6146743 1,07761,168 7196803 5106676
Sequence Length, range 20–9,696 2–13,936 23–14,514 50–11,862 1–12,269
Experimental Data
Sequences with Assigned MS peptides (% of dataset) 17% 19% 27% 20% 49%
Average sequence coverage of MS peptides 10.7% 13.4% 8.6% 12.5% 29.9%
Sequences with Filtered EST alignments (% of dataset) 58% 62% 75% 72% 85%
Sequences with MS peptides AND EST (% of dataset) 15% 17% 25% 18% 48%
doi:10.1371/journal.pone.0003899.t002
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PLoS ONE | www.plosone.org 4 December 2008 | Volume 3 | Issue 12 | e3899Figure 2. Examples of clusters of similar predicted amino acid sequences (red lines) with MS peptide hits (shown as open black
blocks on amino acid sequences) and aligned ESTs (blue lines below amino acid sequence clusters), with EST translation
directionality indicated. Grey lines indicate areas where sequences differ and are not aligned. Identifiers are listed on the right. a. Cluster of a
TigrScan (TgTigrScan_7144) and Release4 (55.m10274) sequence. The TigrScan sequence has additional 59 and 39 regions (exons) compared to the
Release4 sequence. The additional regions are verified by MS hits. There are no TwinScan, Glimmer, or known NR sequences in this MS validated
coding region. b. Cluster of a Glimmer, TigrScan , Release4, and TwinScan sequence, all validated by MS peptide hits. The Glimmer sequence
(TgGlmHmm_2826) has an additional MS validated 59 region. The TigrScan ( TgTigrScan_4753) sequence does not have an exon that is included in
the Glimmer, Release4, and TwinScan sequences and that is supported by both MS and EST data. c. Cluster of a Glimmer (TgGlmHmm_2506)
sequence, three TwinScan (TgTwinScan) sequences, and three Release4 sequences. The TwinScan and Release4 methods each predict three distinct
proteins from this coding region whereas the Glimmer method predicts one. The distribution and location of the MS peptides on the Glimmer
sequence indicates that the full length protein is likely to be present in the proteome. However, the shorter splice variants may also be real proteins.
An example of the proteomics data confirming the existence of a continuous portion of the sequence is the group of MS peptides indicated by
arrows.
doi:10.1371/journal.pone.0003899.g002
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Clustering proteins by sequence similarity may group together
paralogs from different genomic locations that emerged through
gene duplication or gene shuffling mechanisms. Therefore, we
explored the homogeneity of the sequence clusters in terms of
genomic localization. First, individual protein sequences were
mapped onto the T. gondii genome. We successfully mapped
27,777 sequences (92% of the combined and redundant dataset)
onto the genome (see Methods). The sequences span an average
length of 5,879 nucleotides and, on average, approximately 52%
of the genomic coding region is exonic. We found 787 sequences
(2.6%) only that can be mapped to multiple locations in the
genome, which suggests a relatively low level of gene duplication
events.
Genomic mappings of the protein sequences determined the
genomic location of 92% of the 14,983 sequence clusters (see
Methods). In approximately 1% of the clusters, a sequence maps
to a different genomic location than the rest of the cluster
members. Approximately 99% of the clusters are composed of
sequences that are transcribed from the same genomic regions.
These clusters of predicted protein sequences may also represent
possible splice variants of the same gene. There are 3,120 and
2,969 genomic regions that are comprised of either an individual
cluster or a co-localized cluster group (see Methods), respectively,
and thus, we estimate that there are 6,089 potential protein-coding
regions in the T. gondii genome. The genomic protein-coding
regions span, on average, 9,924 nucleotides and, since the T. gondii
genome is about 65 Mb, approximately 7% of the genomic
sequence is intergenic. The estimated percentage of the genome
that accounts for coding regions is larger than what has been
previously reported for chromosome Ia (56.7%) and Ib (58.1%)
[25], which could be a reflection of the increased number of false
positive protein sequences that arise from a larger variety of
analyzed gene prediction algorithms or possible characteristic
differences among the T. gondii chromosomes.
High throughput experimental validation of the T. gondii
proteome
We explored the T. gondii proteome by performing high
throughput, tandem mass spectrometry (MS/MS) experiments
on T. gondii plasma membrane, cytoskeletal, and cytosolic protein
preparations and cross referencing the MS-derived peptides with
the computationally generated and experimentally derived amino
acid sequences of the hypothetical T. gondii proteome. Expressed
sequence tag data was used to provide further experimental
support for some sequences in the hypothetical T. gondii proteome.
The 252 MS/MS experiments provided 7,270 unique proteo-
lytic peptides that identified 6,438 sequences (21% of the
combined dataset). The average peptide coverage of the MS/
MS supported sequences is 13.5%. The percentages of sequences
with an assigned peptide are similar for the TigrScan, TwinScan,
Glimmer, and Release4 datasets (17%, 19%, 27%, and 20%,
respectively) while the percentage is substantially higher for the
NR dataset (49%) (Table 2). The average peptide coverages are
also similar for the TigrScan, TwinScan, Glimmer, and Release4
sequences yet significantly higher for the NR sequences (10.7%,
13.4%, 8.6%, 12.5%, respectively, compared to 29.9%) (Table 2).
The fact that the NR dataset has a higher percentage of sequences
with assigned peptides and a higher average coverage seems
intuitive as is a reflection of the fact that these sequences are
believed to be more reliable, because, in general, they are
experimentally derived. These sequences certainly do not
represent a comprehensive or uniform sample of the T. gondii
proteome and thus, no assumptions can be made about the quality
of the sequences or coverage of the proteome by this dataset with
respect to the predicted datasets. The observation that each
protein prediction method has a similar degree of experimental
validation, along with the disparate nature of the sequences
predicted by each method, indicates that each method predicts the
proteome with a similar level of accuracy.
There are 2,477 clusters (17% of the total clusters) that contain
a sequence with an assigned MS/MS peptide. The portions of the
MS/MS supported clusters that contain a TigrScan, TwinScan, or
Release4 sequence are similar (60.75%, 65.60%, and 67.62%,
respectively) while the portion that contains a Glimmer sequence is
slightly lower (56.72%) (Table 5). The discrepancy in the accuracy
of the protein prediction methods can be explained by the fact that
there are fewer Glimmer sequences as compared to the other
Table 4. Distribution of cluster sizes (number of sequences
per cluster) for the CD-HIT clustered combined protein
dataset.
Cluster Size (sequences per cluster) Number of Clusters
18 , 2 8 1
22 , 4 7 6
31 , 8 5 0
41 , 5 7 7
54 3 0
61 6 0
71 0 4
84 2
92 3
10 12
.10 28
doi:10.1371/journal.pone.0003899.t004
Table 5. Number of all sequence clusters and clusters
supported by MS data, EST data, and MS and EST data,
respectively.
Predicted Protein Types
TigrScan TwinScan Glimmer Release4 NR
14,983 Total Clusters
sequence type (# clusters) 7,914 7,093 4,916 7,389 889
% of Total Clusters 53% 47% 33% 49% 6%
2,477 MS Clusters
sequence type (# clusters) 1,505 1,625 1,405 1,675 384
% of MS Clusters 61% 66% 57% 68% 16%
9,242 EST Clusters
sequence type (# clusters) 4,954 4,851 3,816 5,645 748
% of EST Clusters 54% 52% 41% 61% 8%
2,275 MS AND EST Clusters
sequence type (# clusters) 1,396 1,507 1,315 1,562 370
% of both MS and EST
Clusters
61% 66% 58% 69% 16%
For each category, the number of clusters with each predicted sequence type is
shown along with the corresponding percentage of the clusters in the
respective category.
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predictions manages to identify all of the proteins that are
supported by MS/MS data; each prediction method is missing 31
to 43% of the validated part of the proteome. In these calculations
we assumed that if there is at least one proteolytic peptide that
matches a sequence in a cluster, then all sequences are validated.
However a proteolytic peptide may not have an overlap with all
sequences in a cluster (Fig. 2a–c). Nevertheless for each type of
protein, due to the relatively dense coverage of MS peptides in
each cluster, a sequence that was present within an MS/MS
supported cluster almost always had a peptide mapped directly to
the sequence ($90% of the occurrences of a sequence within the
MS/MS supported cluster). This indicates that there is exper-
imental evidence to support each sequence within the cluster,
despite differences in splicing and/or predictions among the
clustered sequences.
According to the various prediction algorithms, the T. gondii
genome is expected to encode approximately 7,800 genes [26,27],
of which 18% were estimated to be life stage specific (,1,400)
[28]. This suggests that our high throughput MS/MS experiments
explored at least one third of the genome of T. gondii tachyzoites
(2,477 clusters). This may be an underestimate if a significant
fraction of our clusters represent two or more gene products.
EST mapping analysis of the hypothetical T. gondii proteome
offers similar conclusions to what were generated from the MS/
MS analysis. It was possible to validate 20,123 sequences (67% of
the combined dataset) with an aligned EST sequence, which
corresponds to 9,242 clusters (62% of the total clusters). The
TigrScan and TwinScan datasets have roughly the same
percentages of sequences that are supported with an EST
alignment (58% and 62%, respectively) while the Glimmer and
Release4 methods have similar and higher percentages of
sequences with an EST alignment (75% and 72%, respectively).
The enrichment of Glimmer sequences with an EST alignment is
likely a result of the Glimmer sequences being, on average, much
longer then the TigrScan, TwinScan, or NR sequences. Thus,
there is a greater chance that a Glimmer sequence will cover part
of the genome that is also sequenced by an EST. The high
percentage of Release4 sequences with an EST alignment is
possibly the result of ESTs (or other genomic data) being included
in the integrated data that was used to derive the Release4
sequences (Table 2).
The percentages of the EST supported clusters that contain
TigrScan, TwinScan, or Release4 sequences are similar (54%,
52%, and 61%, respectively) whereas the percentage that contains
a Glimmer sequence is lower (41%) (Table 5). A vast majority
($96%) of the sequences within the EST supported clusters have
an EST alignment, again indicating that each sequence, within the
cluster, has experimental support despite possible splicing or
prediction differences.
The EST alignments were filtered based on requirements for
minimum alignment length and sequence identity in order to
differentiate cases in which the amino acid sequences were
supported by a strong alignment from the cases in which the
alignment indicated a paralog rather than a direct validation of the
sequence by genomic data. Without filtering, there are 21,989
sequences that have EST alignments, which is only 9.3% more
than the number of sequences with filtered EST alignments
(20,123 sequences) and which represents only a 6% increase in the
percentage of the hypothetical proteome that is supported by
experimental EST evidence. The consistency in the number of
amino acid sequences with filtered and non-filtered EST
alignments indicates that, within the subset of sequences that are
supported by EST data, there are strong similarities between the
protein sequences and the EST sequences.
The MS proteomics data were cross-referenced with the EST
genomics data. There are 5,881 sequences (19.5% of the
combined dataset) that are experimentally supported by both an
assigned MS/MS peptide and a filtered EST alignment, which
one might consider to be the most highly validated proteins in the
compiled proteome. The sequences with both types of exper-
imental data correspond to 2,275 clusters (15.2% of the total
clusters). The average MS/MS peptide coverage of sequences that
are supported by MS and EST data or exclusively by MS data
alone is 14.3% and 5.25%, respectively. The difference in peptide
coverage may be a result of the proteins with EST data being more
highly expressed in the T. gondii proteome compared to those
without EST alignments.
Clusters that are supported by both MS data and EST data
have a comparable portion of Glimmer, TigrScan, TwinScan, and
Release4 sequences (58%, 61%, 66%, and 69%, respectively)
(Table 5). Therefore, the gene prediction algorithms exhibit a false
negative rate of 31 to 42%, which is the portion of the
experimentally validated coding regions (clusters) (MS and EST)
that are completely missed by individual prediction methods.
While it is not possible to precisely identify the false positive
predictions (predicted amino acid sequences that are not real
proteins) from these data, it is clear that the rate of false positive
predictions must be substantial for each prediction method.
Figures 2a–c illustrate some of the sequence clusters with their
corresponding experimental data. The sequence cluster in the first
example (Fig. 2a.) is validated with MS peptide hits as well as EST
data, but there are only two predicted protein sequences, one from
TigrScan (TgTigrScan_7144) and one from Relase4 (55.m10274),
i.e. all other prediction methods failed to predict the protein
coding region that is represented by this cluster. Moreover, the
peptide coverage illustrates that the longer TigrScan prediction is
either a valid splice variant of the coded protein or the Release4
prediction failed to identify both the N and C terminal segments of
the protein, both of which have been validated by MS data and, in
the case of the N-terminal, EST data. The second example cluster
(Fig. 2b.) is composed of sequences from all four prediction
methods, albeit with significant differences among the sequences.
For instance, the TigrScan prediction suggests two separate
proteins in this clusters, or genomic location, while MS peptides
and EST evidence points to a continuous protein sequence. In
addition, the N terminal segment that is unique to the Glimmer
prediction (TgGlmHmm_2826) is confirmed by both an MS
peptide and two EST alignments. The third example (Fig. 2c.)
shows a cluster with a variety of vastly different predictions from
three methods (TigrScan fails to predict a protein in this cluster).
The arrows pointing to the Glimmer prediction indicate MS
peptides that confirm areas of the protein sequence where other
models predicted gaps (TgTwinScan_2224 and TgTwin-
Scan_2226 as well as 641.m00177 and 641.m00176), suggesting
that the continuous protein sequence exists at least as one splice
variant. In addition, the N-terminal tail of the Glimmer prediction
is confirmed with a very high coverage of MS peptides and
numerous EST alignments, while this segment was missed by all
other prediction methods.
Functional annotation of the T. gondii proteome
Each protein sequence in the combined dataset was scanned
against the PFAM database [31], a collection of protein domains
and families, using pfam_scan.pl version 0.5, available from
ftp.sanger.ac.uk. The output was parsed to find the PFAM domain
names and locations for each sequence. Phobius (version 1.01)
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predictor, was used to perform the transmembrane domain and
signal peptide predictions.
There are 13,430 sequences (45% of the combined dataset) with
at least one PFAM domain annotation compared to 20,326
sequences (67%) that are annotated with orthologs predicted from
pairwise BLAST [22] alignments with sequences from the NCBI
NR database. The percentage of proteins that have PFAM
domains compares well with the published results of PFAM 22.0,
which reports that 49% of 213 T. gondii UniProtKB/TrEMBL
deposited proteins have at least one PFAM domain [31].
Sequences with PFAM domains correspond to 5,741 clusters
(38% of the total clusters). The TigrScan, TwinScan, and Release4
sequence sets have similar percentages of sequences with PFAM
domains (36%, 43%, and 44%, respectively). The percentages of
sequences with PFAM domains are similar for the Glimmer and
NR sequence sets (62% and 69%, respectively). The higher
proportion of PFAM domains found in the NR sequences,
compared to TigrScan, TwinScan, or Release4, is probably a
consequence of a higher level of confidence in these sequences, as
they are typically experimentally derived. However, the higher
proportion of PFAM domains for the Glimmer sequences is likely
a consequence of the fact that they are much longer, on average,
than the other sequence types (Table S1), so an individual
sequence will coincide with a bona fide coding region within the
genome with a higher probability than the other protein types. In
summary, PFAM annotations are used to infer a certain degree of
biological validity for approximately 45% of the compiled T. gondii
proteome.
There are 6,927 sequences (23% of the combined dataset) that
have predicted transmembrane domains, which corresponds to
3,730 clusters (25% of the total clusters), and which is consistent
with the proportion of membrane proteins that have been
predicted in other genomes (20–35%) [33]. There are 4,330
sequences (14% of the combined dataset) that have predicted
signal peptides, which corresponds to 2,601 clusters (17% of the
total clusters). The percentages of sequences with signal peptides
and transmembrane regions are consistent among the individual
datasets. Transmembrane proteins of T. gondii are of particular
interest because of their role in the interaction and adhesion of
the parasite to the host cell and their link to the virulence of the
parasite. These critical functions make some subsets of mem-
brane proteins good candidates for chemotherapeutic targets.
Meanwhile sequences with signal peptides generally refer to
proteins that are secreted from the cell. In the case of T. gondii,
secreted proteins include those of the micronemes, rhoptries, and
dense granules, which are integral parts of the unique process of
interaction, invasion, and infection of the host cell by T. gondii
[34].
Comparative genomics of the T. gondii proteome
Each sequence was compared against other Apicomplexan
genomes, against the human genome, and against the complete
NCBI NR database (Table S1).
The amino acid sequences of the hypothetical proteome of T.
gondii were searched against the complete NCBI NR database,
Apicomplexa proteins, and human proteins to identify unique and
conserved proteins. In general, 67% of the hypothetical T .gondii
proteome (59% of the clusters) has a homologous sequence in NR
and 64% has an Apicomplexan ortholog (58% of the clusters).
Approximately 52% of T. gondii sequences (57.5% of the clusters)
are unique as compared to the human genome and, thus, fulfill a
primary requirement of chemotherapeutic target candidates.
EPIC-DB: Experimental ProteomICs DataBase
All experimental data, annotations, protein cluster information
and comparative genomics data are organized into a relational
database (EPICDB) that is publicly accessible at http://www.
fiserlab.org/epicdb. In addition, a summary of the data and
information about reagents generated from the Toxoplasma gondii
MS experiments are available from the Resource Center for
Biodefense Proteomics Research website http://www.proteomics-
resource.org/.
Discussion
The proteomics study presented here is one of the largest of a
genome and certainly the most comprehensive analysis and
validation of the T. gondii proteome to date identifying novel
proteins and offering unique insights into its gene structure. We
experimentally validated with MS experiments 6,438 distinct
proteins that can be clustered into 2,477 groups and account for
approximately one third of the T. gondii genome.
Further, this analysis provides important novel information,
with respect to the T. gondii proteome, since 3,838 (60%) of the
experimentally identified proteins have been annotated as
‘‘hypothetical’’, ‘‘putative’’ or ‘‘predicted’’ in the NCBI NR
database. Additionally 609 MS identified T. gondii proteins are
unique as compared to any known organisms, providing an
important subset of validated proteins for drug targeting.
While the genomes of many organisms have been sequenced,
there are relatively limited amounts of experimental protein data
to accurately annotate these genomes or to validate the
computational gene prediction methods. The current study offers
a way to address this ubiquitous problem by integrating genomics
and proteomics data. The large scale experimental validation of
the hypothetical T. gondii genome shows a false negative rate for
various gene prediction methods of about 31–42% (proteins that
were confirmed experimentally by both MS and EST data but
missed by one or more of the computational gene prediction
methods) and experimentally confirms earlier anecdotal reports
that gene prediction algorithms operate with a substantial false
negative rate [29,30].
This study demonstrates that genome analysis coupled with
experimental proteomics data is essential to benchmark and
improve the accuracy of gene prediction methods and facilitates
insights into gene structure and splice variability within genomes.
Materials and Methods
Protein sequence datasets
All available T. gondii protein sequences were compiled from five
datasets; TigrScan (8,336 sequences), TwinScan (7,588), Glim-
merHMM (4,954), Release4 (7,793), and NR sequences (1,526).
TigrScan, TwinScan and GlimmerHMM sequences were down-
loaded as FASTA files of protein sequences from http://www.
toxodb.org/common/downloads/release-3.3/Genome/pep/. A
FASTA file of Release4 sequences was downloaded from http://
www.toxodb.org/common/downloads/release-4.0/TgondiiAnno-
tatedProteins.fa. The NR sequence dataset was obtained from the
NCBI Entrez Protein Database, which was filtered, by the organism
name, for Toxoplasma gondii (As of July 2008, predicted genes/
proteins from T. gondii genome analysis have not been deposited to
NCBI or GenBank databases). The five datasets were combined to
provide a comprehensive set of all available protein sequences for
the Toxoplasma gondii proteome and comprised 30,197 sequences.
This is a redundant database as different prediction methods may
identify the same sequence with different names.
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sequences
Identical or nearly identical sequences in the combined dataset
were grouped in order to assess the overlap among the four gene
prediction methods. A BLAST [22] search was performed
(without low complexity filtering and with an e-value of
e,0.001) for each sequence against the combined dataset.
Sequences in each alignment were evaluated for overlap and
sequence identity. For sequences longer than 100 residues, two
sequences in an alignment were considered identical if the
sequential overlap and the sequence identity within the overlap
were both 99% or greater. If both the query and subject hit
sequences 100 amino acids or smaller the two sequences were
required to be within one amino acid in terms of length and
sequence identity. Groups containing only NR sequences (672
groups) were not included in the analysis of the computational
prediction methods.
Clustering the protein dataset
The combined, redundant dataset was clustered using CD-HIT
[23]. The sequences are grouped by a given sequence identity
threshold, which corresponds to the local sequence similarity. The
longest sequence in each cluster is designated as the ‘‘represen-
tative’’ sequence, which is a CD-HIT terminology. The sequence
identities are calculated for the shorter sequences with respect to
the representative. The requirement to compare each sequence to
the longest sequence in the cluster is inherent in the clustering
algorithm. However, we do not extend this terminology to
designate the longest sequence to literally represent all the
clustered sequences. The band-width allowance for the sequence
alignments was set to 1,000 gaps in order to compare sequences
with very different lengths but that may share a short common
segment. Clustering was performed in the most accurate mode
where each sequence is added to the cluster to which it is the most
similar rather than to the first cluster for which the sequence
identity threshold is met. CD-HIT implements a greedy
incremental clustering algorithm, which orders the sequences by
decreasing length and makes the longest sequence the represen-
tative sequence of the first cluster. The next sequence is evaluated
by being compared to the representative sequence of the original
cluster and if it satisfies the sequence identity threshold it is added
to the cluster. Otherwise it becomes the representative sequence of
a new (second) cluster. Each successive sequence is evaluated by
being compared to the representative sequences of each cluster
and is either added to a cluster or becomes the representative
sequence of a new cluster. One implementation of the algorithm
clusters the sequences into the first cluster for which the minimum
sequence identity threshold is satisfied. Thus, the first clusters
could be artificially large. However, the clustering presented here
evaluates each sequence against all the clusters and includes the
sequence in the cluster for which it shows the highest sequence
identity.
In order to evaluate the redundancy in the dataset, the
sequences were clustered for decreasing sequence identity
thresholds and the resulting numbers of clusters were analyzed.
A linear relationship exists between the number of clusters and the
sequence identity threshold for sequence identity threshold levels
from 95% to 70% (data not shown). There is not a specific level of
redundancy in the dataset that dictates inherent clusters of the
sequences.
For each cluster within a CD-HIT sequence identity threshold
level, the representative sequence was aligned to all other
sequences in the cluster using BLAST2SEQ (without gaps and
without low complexity filtering). The BLAST sequence identity
and alignment coverage were evaluated for each sequence
alignment. The sequence identity was defined as the number of
identities in the alignment divided by the alignment length. The
alignment coverage was defined as the alignment length divided by
the length of the shorter sequence. The frequency of intra-cluster
BLAST alignment percent identities and alignment coverages
were computed for various CD-HIT sequence identity threshold
levels from 100% to 70%. As the CD-HIT sequence identity
threshold level decreases the frequency of cluster members with
lower quality alignments increases. However a distinct shoulder
forms around the 90–95% sequence identity clustering level,
therefore we identified the 90% sequence identity threshold as the
lower limit of sequence identity that produces clusters of highly
homologous proteins (Fig. 3a–b).
Mapping protein sequences to genomic locations
The genomic sequence for the ME49 strain was downloaded
from ToxoDB.org. Each chromosome’s nucleotide sequence was
translated in 3 consecutive reading frames in both the forward and
reverse directions. A dataset of 2,622,472 potential open reading
frames was created by dividing the 6-frame translations into any
sequences that occurred between two genomic STOP codons. To
determine the genomic location of a protein sequence a BLASTP
(without low complexity filtering and without gaps) search was
performed for the protein sequence against a custom database of
the 2,622,472 generated open reading frames. The resulting local
alignments were filtered to eliminate any alignments with an e-
value greater than 10
24 or a percent identity below 80%. For cases
in which the protein sequence was spliced to multiple exons in the
genome the BLAST search produced multiple, highly significant,
local alignments rather than aligning the complete protein
sequence to a single genomic interval. Our mapping algorithm
examined all possible combinations of local alignments in order to
identify cases in which a sequence could have multiple mapping
options to the genome, i.e., duplicated genes. Each valid alignment
configuration was converted to genomic nucleotide positions since
the chromosomal locations of the open reading frames were
known. This process was repeated for each local alignment within
the protein query thus elucidating the physical mapping as well as
the intron/exon structure of the protein sequence. 80% of the
sequence was required to be mapped to the genome in order to
constitute a successful mapping of the protein to the genome.
There are 2,420 sequences, of the 30,197 sequences in the
combined dataset, that can not be mapped to the genome; 155
sequences have no BLAST alignments to any of the translated
genomic open reading frames, 376 sequences have no BLAST
alignments that meet the significance requirements, and 1,889
proteins are not mapped because significant portions of the
sequences cannot be aligned to the genome. The unmapped
sequences are likely to be predicted from scaffolds that are not
integrated into the genome.
Genomic locations of sequence clusters
The genomic locations of the protein sequences were used to
localize CD-HIT clusters. The location of a genomic region of a
CD-HIT cluster was defined by the sequence within the cluster
that spanned the longest genomic region, including exons and
introns. The genomic locations of each sequence, within a cluster,
were compared in order to identify cases when proteins with
similar sequences were derived from different genomic locations.
The genomic locations of the sequence clusters were used to
determine the distribution of the coding regions in the genome.
Each chromosome was scanned in both directions. Clusters that
had overlapping genomic regions and the same translation
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PLoS ONE | www.plosone.org 9 December 2008 | Volume 3 | Issue 12 | e3899Figure 3. a. Histogram of distribution of pairwise sequence coverages within gene prediction clusters. Different curves refer to different sequence
identity thresholds used for clustering. Color purple, red, brown, dark purple, pink, blue, cyan corresponds to cutoff values of 100%, 95%, 90%, 85%,
80%, 75%, 70%, respectively. b. Histogram of distribution of pairwise sequence identities within gene prediction clusters. Different curves refer to
different sequence identity thresholds used for clustering. Color purple, red, brown, dark purple, pink, blue, cyan corresponds to cutoff values of
100%, 95%, 90%, 85%, 80%, 75%, 70%, respectively.
doi:10.1371/journal.pone.0003899.g003
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genomic regions spanned by the co-localized cluster regions were
defined as potential protein coding regions.
Growth of T. gondii in vitro
RH strain T. gondii were grown in human fibroblasts in DME
media with 10% fetal calf serum and 1% Penicillin Streptomycin
(GIBCO-BRL) in a 5% CO2 incubator. Parasites were transferred
to fresh culture human fibroblast monolayers biweekly. The
absence of Mycoplasma contamination was monitored monthly
using a PCR method (GIBCO-BRL).
Purification of membrane and cytoskeleton protein from
T. gondii
1.2610
10 purified T. gondii RH strain tachyzoites from tissue
culture were resuspended in 20 ml of SMDI buffer (250 mM
Sucrose, 10 mM MOPS-KOH, pH 7.2, 2 mM DTT, 16protease
inhibitor cocktail) and disrupted by French press at a pressure of
1000 PSI, medium setting. The lysate was centrifuged at 7566ga t
4uC for 10 min to pellet unbroken cells. Intact parasites and large
debris were resuspended in 10 ml SMDI buffer and disrupted
once more by French press at a pressure of 1000 PSI, medium
setting. The pooled supernatant was centrifuged at 25,0006ga t
4uC for 20 min. The supernatant was saved for analysis as the
cytosolic fraction. The pellet was resuspended in 10 ml of 30%
Percoll in SMDI buffer. After centrifugation at 75,0006gi na n
ultracentrifuge (Rotor TLA 100.3; 30,000 rpm) at 4uC for 25 min,
the top band was collected from the self-generated gradient. The
band was diluted in SMDI buffer and spun at 100,0006g for
90 min. at 4uC (Rotor TLA 100.3; 40,000 rpm). A band collected
between the buffer and resultant Percoll cushion contained the T.
gondii ghosts consisting of membranes and cytoskeleton [18].
Membrane fraction. To isolate the membrane fraction the
T. gondii ghosts were resuspended in an equal volume of 2%
thioglucopyranoside in 40 mM Tris pH 7.6 by pipeting the
mixture up and down 10 times (suspension kept on ice) followed by
a brief vortex. After centrifugation at 20,0006g in an Eppendorff
centrifuge for 20 min. at 4uC, the supernatant was saved as
membrane fraction (extraction 1). This extraction was repeated
twice with 300 ml of 1% thioglucopyranoside (to make extractions
2 and 3). These fractions were then frozen in liquid nitrogen and
stored at 280uC until used for protein analysis.
Cytoskeleton fraction. Insoluble material, which remained
after the membrane fraction extraction, was washed twice with
40 mM Tris pH 7.6. Following this washing step the material was
solubilized in 500 ml of urea lysis buffer (7.5 M Urea, 2.5 M
Thiourea, 40 mM Tris pH 7.6, 2.5% Octyl-b-glucoside, 6.25 mM
TCEP, 1.256 Proteinase inhibitor) followed by homogenization
on ice 10 times using a Potter homogenizer. The material was then
centrifuged at 8,000 rpm for 10 min at 4uC and the supernatant
was collected and saved. This extraction was repeated twice on the
remaining pellet using 300 ul of the urea lysis buffer and the
supernatants were pooled with the initial extraction to produce the
cytoskeleton fraction. This fraction was then frozen in liquid
nitrogen and stored at 280uC until used for protein analysis.
High throughput mass spectrometry
Nanospray LC-MS/MS was performed on a LTQ linear ion
trap mass spectrometer (LTQ, Thermo, San Jose, CA) interfaced
with a TriVersa NanoMate nanoelectrospray ion source (Advion
BioSciences, Ithaca, NY). An Ultimate
Plus nano-HPLC system
with a Famous autosampler (Dionex Corporation, Sunnyvale,
CA), was coupled with the TriVersa NanoMate. Peptides were
loaded on a C18 m-Precolumn
TM Cartridge (5 mm, 100A ˚, 300 mm
i.d.9 5 mm) from the autosampler with a 25 ml sample loop at a
flow rate of 15 ml/min. After injection of sample, 20 mL, and
washing for 20 minutes, the precolumn was switched in line with
the analytical column, a C18 PepMap100, 3 mm, 100 A ˚,7 5mm
i.d. 9 150 mm (Dionex Corporation, Sunnyvale, CA). Mobile
phase B (80% acetonitrile/water+0.1% formic acid) was increased
from 2% to 55% over 70 minutes, held for 5 minutes, increased to
95% over 20 minutes and held at 95% B for 5 minutes. The flow
rate used was 250 nL/min and mobile phase A consisted of 5%
acetonitrile/water+0.1% formic acid. The four most intense ions
having a charge state between +2t o+4, determined from an initial
survey scan from 300–1800 m/z, were selected for zoom scan and
MS/MS. MS/MS was performed using an isolation width of 2 m/
z, normalized collision energy of 35%, a minimum signal intensity
of 1000 counts, and the dynamic exclusion option enabled. Once a
certain ion is selected twice for MS/MS in 30 sec, this ion is
excluded from being selected again for MS/MS during the next
period of 120 sec. Dta files were created from the raw LTQ mass
spectrometer LC-MS/MS data. The created dta files were then
merged using the merge script tool from Matrix Science (http://
www.matrixscience.com). The subsequent combined merge file
was used to search the database of compiled T. gondii proteins
using the following parameters with MASCOT [24] (in-house):
trypsin, 2 missed cleavages; variable modifications of carbamido-
methylation (Cys), deamidation (Asn and Gln) and oxidation
(Met); monoisotopic masses; peptide mass tolerance of 3.0 Da;
product ion mass tolerance of 0.6 Da. Peptides with a 95%
significance score were accepted only. Each identified protein
sequence was categorized according to the highest ion score of all
of it’s assigned peptides; 76% of the proteins had a high ion score
more than 60, while 24% of the proteins had a high ion score
between 30 and 60.
EST data analysis
The EST dataset was obtained by downloading the NCBI EST
‘‘others’’ database (ftp://ftp.ncbi.nih.gov/blast/db/). The FASTA
definition lines were searched and the sequences were selected for
the organism name ‘‘Toxoplasma gondii’’. A custom T. gondii EST
database was constructed for the resulting 129,736 sequences. A
TBLASTN (with an e-value requirement of 10
210 and without low
complexity filtering) search was performed for each protein
sequence against the custom database of T. gondii EST sequences.
For each query sequence, the EST alignments were filtered to
include only the ESTs with a sequence identity of greater or equal
to 90% and an alignment length of 30 or more residues.
Supporting Information
Table S1 Sequence annotation (PFAM, Transmembrane do-
mains, Signal peptides) for sequence of each prediction type.
Found at: doi:10.1371/journal.pone.0003899.s001 (0.04 MB
DOC)
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